Neuronetics
Neuronetics is a medical technology company that designs, develops, and markets non-invasive therapies for psychiatric disorders. Its flagship product, NeuroStar Advanced Therapy System, uses transcranial magnetic stimulation to treat adult patients with major depressive disorder in office-based settings.
Top Stages
1 past transactions
Greenbrook
Acquisition in 2024
Greenbrook TMS Inc. operates a network of outpatient mental health service centers across the United States, specializing in transcranial magnetic stimulation (TMS) therapy. This FDA-cleared, non-invasive treatment offers electromagnetic stimulation to brain regions involved in mood regulation, primarily targeting major depressive disorder and other mental health conditions. Founded in 2011 and headquartered in Toronto, Canada, Greenbrook TMS manages approximately 121 treatment centers nationwide, providing accessible care for individuals seeking innovative solutions for their mental health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.